Actavis Plans Job Cuts, China Expansion for Allergan
This article is for subscribers only.
Actavis Plc, which this month agreed to buy Allergan Inc. for $66 billion, plans to cut employees and expand in China, executives from the companies said.
Actavis Chief Executive Officer Brent Saunders said there are overlaps in corporate functions, including human relations and finance, though he hasn’t yet quantified how many positions will be eliminated.